AXSM peer analysis
Axsome Therapeutics (AXSM) against its competitors: price, today's move, 1-year return and market value side by side.
- AXSM's peers: AVXL (Anavex Life Sciences), DFTX (Definium Therapeutics), DNLI (Denali Therapeutics), JAZZ (Jazz Pharmaceuticals), NBIX (Neurocrine Biosciences), NMRA (Neumora Therapeutics), PRAX (Praxis Precision Medicines), RAPP (Rapport Therapeutics).
AXSM and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVXL Anavex Life Sciences | $0.62 | -7.13% | -82.78% | $57.46M |
| DFTX Definium Therapeutics | $28.05 | -4.85% | – | $3.84B |
| DNLI Denali Therapeutics | $18.19 | -0.05% | 7.51% | $2.92B |
| JAZZ Jazz Pharmaceuticals | $230.62 | -2.47% | 30.97% | $14.80B |
| NBIX Neurocrine Biosciences | $150.57 | -3.84% | 9.06% | $15.24B |
| NMRA Neumora Therapeutics | $0.35 | -5.40% | -86.34% | $65.48M |
| PRAX Praxis Precision Medicines | $275.00 | -11.55% | 45.26% | $7.69B |
| RAPP Rapport Therapeutics | $23.16 | -1.82% | -13.84% | $1.11B |
| SUPN Supernus Pharmaceuticals | $28.00 | -1.23% | -37.64% | $3.30B |
| XENE Xenon Pharmaceuticals | $37.00 | -1.49% | -8.98% | $3.64B |
| AXSM Axsome Therapeutics | $129.36 | -4.66% | -11.86% | $6.80B |